Results 111 to 120 of about 1,312,052 (154)

High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA. [PDF]

Pediatr Rheumatol Online J
Hügle B, Horneff G, Haas JP.
europepmc   +1 more source

Age-Specific Risk Factors for Cancer in a Long-Term Korean Cohort of Patients with Ankylosing Spondylitis Treated with TNF Inhibitors. [PDF]

J Clin Med
Lee YJ, Kim M, Ahn SM, Hong S, Oh JS, Lee CK, Yoo B, Kim YG.   +7 more
europepmc   +1 more source

Combination therapy with TNF inhibitors plus biologics targeting type 2 inflammatory conditions in patients with rheumatoid arthritis: a case series. [PDF]

Rheumatol Adv Pract
Ocon AJ, Abdalla A, Vengilote R, Ramsey A, Mustafa SS.   +4 more
europepmc   +1 more source

TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis. [PDF]

Rheumatol Adv Pract, 2023
Schäfer A, Kovacs MS, Eder A, Nigg A, Feuchtenberger M.   +4 more
europepmc   +1 more source

A real-world safety analysis of infection-related adverse events associated with belimumab, rituximab, and TNF inhibitors using the FAERS database. [PDF]

Sci Rep
Sisi W, Sheng D, Yuting H, Rong Y, Shao L.   +4 more
europepmc   +1 more source

Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis. [PDF]

Cochrane Database Syst Rev
Cagnotto G, Juhl CB, Ahlström F, Wikström F, Bruschettini M, Petersson I, Dreyer L, Compagno M.   +7 more
europepmc   +1 more source

Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis. [PDF]

Cochrane Database Syst Rev
Cagnotto G, Bruschettini M, Stróżyk A, Scirè CA, Compagno M.   +4 more
europepmc   +1 more source

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis. [PDF]

Ocul Immunol Inflamm
Gangaputra SS, Newcomb CW, Ying GS, Dreger KA, Fitzgerald T, Artornsombudh P, Kothari S, Liesegang TL, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Lowder CY, Goldstein DA, Holland GN, Jaffe GJ, Davis JL, Acharya NR, Latkany PA, Read RW, Garg SJ, Liederman YI, Buchanich JM, Kempen JH, For The Systemic Immunosuppressive Therapy For Eye Diseases Site Cohort Study Research Group.   +28 more
europepmc   +1 more source

TNF inhibitors and cardiovascular risk: Friend or foe? [PDF]

J Eur Acad Dermatol Venereol
Gelfand JM, Garshick M.
europepmc   +1 more source

TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination. [PDF]

RMD Open
Kummer LY, Kuijper LH, Fernández Blanco L, Bos A, Kreher C, Verstegen NJ, Duurland MC, Konijn VA, Jorritsma T, Tempert M, Menage C, Steenhuis M, van Gils MJ, Claireaux M, Garcia-Vallejo JJ, D'Haens GR, Löwenberg M, Volkers AG, van Dam KP, Stalman EW, Wieske L, Tas SW, Boekel L, Wolbink G, Rispens T, Kuijpers TW, Eftimov F, van Ham SM, Ten Brinke A.   +28 more
europepmc   +1 more source